Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Harris

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Urology|May 1, 1997
Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng./ml. or lessC H Harris, B L Dalkin, E Martin, et al.
Seminars in Dialysis|July 25, 2012
Starting dialysis early: no survival, quality of life, or cost advantagesThida M M Myint, Bruce A Cooper, Carol A Pollock, et al.
Frontiers in Physiology|August 23, 2021
The Role of Macrophages in Kidney FibrosisXiaoling Wang, Jianwei Chen, Jun Xu, et al.
Neuroscience Letters|July 17, 1990
MK-801-induced sprouting by CGRP immunoreactive primary afferent fibers in the dorsal spinal cord of the ratC H Harris, E L Fagan, R L Shew, et al.
Kidney International|October 10, 2020
Ethics of kidney care in the era of COVID-19Dominique E Martin, Jordan A Parsons, Fergus J Caskey, et al.
Kidney International|October 31, 2020
Providing care for patients with kidney failure over the next decadeDavid C H Harris, Simon J Davies, Fredric O Finkelstein, et al.
Renal Failure|September 13, 2005
Effect of nephrotoxins on tubulointerstitial injury and NF-kappaB activation in Adriamycin nephropathyGopala K Rangan, Yiping Wang, Yuet-Ching Tay, et al.
British Journal of Urology|June 1, 1997
Prostatic asymmetry as a risk factor for prostatic carcinoma: serial prostate-specific antigen monitoring and cancer detectionJ G Hansen, B L Dalkin, C H Harris, et al.
Kidney International|September 13, 2003
Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal diseaseLukas Kairaitis, Yiping Wang, Ling Zheng, et al.
Current Protocols in Immunology|February 3, 2015
Adriamycin nephropathy in BALB/c miceYuan Min Wang, Yiping Wang, David C H Harris, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Urology|May 1, 1997
Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng./ml. or lessC H Harris, B L Dalkin, E Martin, et al.
Seminars in Dialysis|July 25, 2012
Starting dialysis early: no survival, quality of life, or cost advantagesThida M M Myint, Bruce A Cooper, Carol A Pollock, et al.
Frontiers in Physiology|August 23, 2021
The Role of Macrophages in Kidney FibrosisXiaoling Wang, Jianwei Chen, Jun Xu, et al.
Neuroscience Letters|July 17, 1990
MK-801-induced sprouting by CGRP immunoreactive primary afferent fibers in the dorsal spinal cord of the ratC H Harris, E L Fagan, R L Shew, et al.
Kidney International|October 10, 2020
Ethics of kidney care in the era of COVID-19Dominique E Martin, Jordan A Parsons, Fergus J Caskey, et al.
Kidney International|October 31, 2020
Providing care for patients with kidney failure over the next decadeDavid C H Harris, Simon J Davies, Fredric O Finkelstein, et al.
Renal Failure|September 13, 2005
Effect of nephrotoxins on tubulointerstitial injury and NF-kappaB activation in Adriamycin nephropathyGopala K Rangan, Yiping Wang, Yuet-Ching Tay, et al.
British Journal of Urology|June 1, 1997
Prostatic asymmetry as a risk factor for prostatic carcinoma: serial prostate-specific antigen monitoring and cancer detectionJ G Hansen, B L Dalkin, C H Harris, et al.
Kidney International|September 13, 2003
Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal diseaseLukas Kairaitis, Yiping Wang, Ling Zheng, et al.
Current Protocols in Immunology|February 3, 2015
Adriamycin nephropathy in BALB/c miceYuan Min Wang, Yiping Wang, David C H Harris, et al.
Pageof 16